We came across a bullish thesis on Harmony Biosciences Holdings, Inc. (HRMY) on Value Investing Subreddit Page by Long-Access-2143. In this article, we will summarize the bulls’ thesis on HRMY. Harmony Biosciences Holdings, Inc. (HRMY)'s share was trading at $30.97 as of April 3rd. HRMY’s trailing and forward P/E were 12.34 and 8.72 respectively according to Yahoo Finance.
Harmony Biosciences, a commercial-stage pharmaceutical company focused on rare neurological disorders, presents a compelling investment case built on a profitable and differentiated product, strong financial...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.